Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cathrine K. Fog-Tonnesen
Arimoclomol as a Potential Therapy for Neuronopathic Gaucher Disease
Related publications
3. Development of Pharmacological Chaperone Therapy for Neuronopathic Gaucher Disease
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Chitinase in Humans Is a Marker for Gaucher Disease. Potential for Monitoring Therapy. 850
Pediatric Research
Child Health
Pediatrics
Perinatology
AB120. Cholelithiasis in a Filipino Child With Chronic Neuronopathic Gaucher Disease: Report of a Case
Annals of Translational Medicine
Medicine
Cost-Effectiveness of Enzyme Replacement Therapy for Type 1 Gaucher Disease
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
PP044 Adherence to Enzyme Replacement Therapy in Gaucher Disease
International Journal of Technology Assessment in Health Care
Health Policy
Neonatal Cholestasis as Initial Manifestation of Type 2 Gaucher Disease: A Continuum in the Spectrum of Early Onset Gaucher Disease
JIMD Reports
Internal Medicine
Genetics
Molecular Biology
Biochemistry
Endocrinology
Metabolism
Diabetes
Gaucher Disease Presenting as Longstanding Splenomegaly and Thrombocytopenia – A Case Report
Pathology
Forensic Medicine
Pathology
High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase
PLoS ONE
Multidisciplinary
Psy97 - Cost-Effectiveness Analysis of Enzyme Replacement Therapy for Type 1 Gaucher Disease
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental